Early prediction of response to Neoadjuvant Immunotherapy in Triple Negative Breast Cancer (TNBC) with DCEMRI

被引：0
|
作者：
Rauch, Gaiane
Guirguis, Mary
Patel, Miral
Candelaria, Rosalind
Mohamed, Rania
Moseley, Tanya
Le-Petross, H. T. Carisa
Leung, Jessica
Whitman, Gary
Lane, Deanna
Scoggins, Marion
Perez, Frances
Sun, Jia
Pashapoor, Sanaz
Xu, Zhan
White, Jason
Wei, Peng
Reed, Brandy
Son, Jong Bum
Hwang, Ken-Pin
Panthi, Bikash
Korkut, Anil
Huo, Lei
Hunt, Kelly
Clayborn, Alyson
Litton, Jennifer
Valero, Vicente
Tripathy, Debu
Yam, Clinton
Yang, Wei
Ma, Jingfei
Adrada, Beatriz
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS05-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS05-07
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Artificial Intelligence Driven Neoadjuvant Chemotherapy Response Prediction in Triple Negative Breast Cancer (TNBC) Unveils Non-linear Feature Interactions
    Huang, Zhi
    Han, Zhi
    Parwani, Anil
    Huang, Kun
    Li, Zaibo
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1459 - 1461
  • [32] Artificial Intelligence Driven Neoadjuvant Chemotherapy Response Prediction in Triple Negative Breast Cancer (TNBC) Unveils Non-linear Feature Interactions
    Huang, Zhi
    Han, Zhi
    Parwani, Anil
    Huang, Kun
    Li, Zaibo
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1459 - 1461
  • [33] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S102 - S102
  • [34] Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
    Perry, Lauren M.
    Sevilimedu, Varadan
    Polidorio, Natalia
    Abuhadra, Nour
    Morrow, Monica
    Plitas, George
    Downs-Canner, Stephanie
    ANNALS OF SURGICAL ONCOLOGY, 2025, : 3991 - 4001
  • [35] EFFICACY OF ADJUVANT VERSUS NEOADJUVANT CHEMOTHERAPY IN HISPANIC/LATINO WOMEN WITH EARLY STAGE, TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Philipovskiy, A.
    Corral, J.
    Heydariana, R.
    Gaur, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 593 - 593
  • [36] Spatial mapping of the immune microenvironment in primary triple-negative breast cancer (TNBC) and association with neoadjuvant therapy response
    Telli, M. L.
    Vinayak, S.
    Khododoust, M. S.
    Gruber, J. J.
    Ford, J. M.
    Sanchez, P.
    Banayan, N.
    Azimi, S.
    Tumeh, P. C.
    Newman, A. M.
    Alizadeh, A. A.
    CANCER RESEARCH, 2019, 79 (04)
  • [37] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [38] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [39] Transcriptomic modification induced by the first cycle of neoadjuvant chemotherapy impacts response to treatment in triple negative breast cancer (TNBC)
    Desmoulins, Isabelle
    Chardin, David
    Richard, Corentin
    Arnould, Laurent
    Cochet, Alexandre
    Humbert, Olivier
    Boidot, Romain
    CANCER RESEARCH, 2023, 83 (05)
  • [40] Prediction of Response to the Anti-EGFR Antibody Panitumumab Combined with Standard Neoadjuvant Chemotherapy in Triple Negative Breast Cancer (TNBC):The Immune and IGFR Pathways
    Penault-Llorca, F.
    Abrial, C.
    Dauplat, M-M
    Privat, M.
    Uhrhammer, N.
    Desrichard, A.
    Bidet, Y.
    Radosevic-Robin, N.
    Cayre, A.
    Aube, C.
    Kwiatkowski, F.
    Bignon, Y-J
    Chollet, P.
    Nabholtz, J-M
    MODERN PATHOLOGY, 2013, 26 : 63A - 63A
12345